Childress Capital Advisors LLC Makes New Investment in Axon Enterprise, Inc $AXON

Childress Capital Advisors LLC bought a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the second quarter, HoldingsChannel reports. The fund bought 258 shares of the biotechnology company’s stock, valued at approximately $214,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. TCTC Holdings LLC lifted its position in Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after buying an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC lifted its position in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after buying an additional 33 shares in the last quarter. Banque Transatlantique SA purchased a new stake in Axon Enterprise in the 1st quarter worth approximately $31,000. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the 1st quarter worth approximately $32,000. Finally, Flaharty Asset Management LLC purchased a new stake in Axon Enterprise in the 1st quarter worth approximately $33,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In related news, President Joshua Isner sold 15,919 shares of the business’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the transaction, the president owned 238,379 shares of the company’s stock, valued at approximately $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 7,891 shares of the business’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares in the company, valued at $108,417,953.80. This trade represents a 5.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 49,932 shares of company stock valued at $37,978,216 in the last three months. 4.40% of the stock is owned by insiders.

Analysts Set New Price Targets

AXON has been the subject of a number of analyst reports. UBS Group reiterated a “neutral” rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Piper Sandler initiated coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 target price for the company. Bank of America lifted their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Finally, Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the company an “overweight” rating in a research note on Friday, July 11th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $841.64.

Axon Enterprise Trading Down 0.9%

NASDAQ:AXON opened at $711.34 on Thursday. Axon Enterprise, Inc has a 12 month low of $397.53 and a 12 month high of $885.91. The firm has a market cap of $55.84 billion, a price-to-earnings ratio of 175.64, a P/E/G ratio of 27.87 and a beta of 1.42. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The company’s 50 day moving average is $757.95 and its 200-day moving average is $705.01.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. During the same quarter last year, the firm posted $1.20 earnings per share. The company’s quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.